Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data

被引:0
作者
Coral Fustero-Torre
María José Jiménez-Santos
Santiago García-Martín
Carlos Carretero-Puche
Luis García-Jimeno
Vadym Ivanchuk
Tomás Di Domenico
Gonzalo Gómez-López
Fátima Al-Shahrour
机构
[1] Spanish National Cancer Research Centre (CNIO),Bioinformatics Unit
[2] Hospital 12 de Octubre,Laboratorio de Oncología Clínico
[3] Spanish National Cancer Research Centre (CNIO),Traslacional, Unidad de Investigación en tumores Digestivos, Instituto de Investigación I+12
来源
Genome Medicine | / 13卷
关键词
Single-cell RNA-seq; Intratumoural heterogeneity; Drug repositioning; Therapeutic clusters; Personalised therapy;
D O I
暂无
中图分类号
学科分类号
摘要
We present Beyondcell, a computational methodology for identifying tumour cell subpopulations with distinct drug responses in single-cell RNA-seq data and proposing cancer-specific treatments. Our method calculates an enrichment score in a collection of drug signatures, delineating therapeutic clusters (TCs) within cellular populations. Additionally, Beyondcell determines the therapeutic differences among cell populations and generates a prioritised sensitivity-based ranking in order to guide drug selection. We performed Beyondcell analysis in five single-cell datasets and demonstrated that TCs can be exploited to target malignant cells both in cancer cell lines and tumour patients. Beyondcell is available at: https://gitlab.com/bu_cnio/beyondcell.
引用
收藏
相关论文
共 640 条
[1]  
Turajlic S(2019)Resolving genetic heterogeneity in cancer Nat Rev Genet. 20 404-416
[2]  
Sottoriva A(2017)Clonal heterogeneity and tumor evolution: past, present, and the future Cell. 168 613-628
[3]  
Graham T(2018)Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics Nat Commun. 9 2983-1366
[4]  
Swanton C(2019)Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells Int J Cancer. 144 1356-436
[5]  
McGranahan N(2020)Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer Nat Cancer. 1 423-74.e5
[6]  
Swanton C(2019)Non-genetic intra-tumor heterogeneity is a major predictor of phenotypic heterogeneity and ongoing evolutionary dynamics in lung tumors Cell Rep 29 2164-468
[7]  
Li X(2020)Single-cell RNA sequencing reveals a heterogeneous response to glucocorticoids in breast cancer cells Commun Biol. 3 126-555
[8]  
Francies HE(2018)Identification of the tumour transition states occurring during EMT Nature. 556 463-503
[9]  
Secrier M(2020)B cells and tertiary lymphoid structures promote immunotherapy response Nature. 577 549-607
[10]  
Perner J(2021)Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing Nat Med. 27 491-575